John Eikelboom
0000-0003-4126-1285
8 papers found
Refreshing results…
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
Missing publications? Search for publications with a matching author name.